Arthur J. Higgins
2017 - DepoMed
In 2017, Arthur J. Higgins earned a total compensation of $4.8M as President and Chief Executive Officer at DepoMed.
Compensation breakdown
| Option Awards | $1,748,923 |
|---|---|
| Salary | $612,308 |
| Stock Awards | $2,349,994 |
| Other | $55,312 |
| Total | $4,766,537 |
Higgins received $2.3M in stock awards, accounting for 49% of the total pay in 2017.
Higgins also received $1.7M in option awards, $612.3K in salary and $55.3K in other compensation.
Rankings
In 2017, Arthur J. Higgins' compensation ranked 2,024th out of 14,666 executives tracked by ExecPay. In other words, Higgins earned more than 86.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,024 out of 14,666 | 86th |
Division Manufacturing | 691 out of 5,772 | 88th |
Major group Chemicals And Allied Products | 187 out of 2,075 | 91st |
Industry group Drugs | 140 out of 1,731 | 92nd |
Industry Pharmaceutical Preparations | 106 out of 1,333 | 92nd |
Source: SEC filing on March 27, 2018.
Higgins' colleagues
We found five more compensation records of executives who worked with Arthur J. Higgins at DepoMed in 2017.
News
Assertio Holdings CEO Arthur Higgins' 2020 pay falls 48% to $2.5M
April 12, 2021
Egalet CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
DepoMed CEO Arthur Higgins' 2019 pay rises 2% to $4.9M
April 20, 2020
Egalet CEO Arthur Higgins' 2018 pay stays at $4.8M
November 6, 2019
DepoMed CEO Arthur Higgins' 2018 pay stays at $4.8M
April 8, 2019